Business

IIFL Asset Management picks up nearly 2% stake in Indo Tech Transformers from promoter

IIFL Asset Management picks up nearly 2% stake in Indo Tech Transformers from promoter

Bliss Gvs Pharma LimitedJune 29, 20265
IIFL Asset Management picks up nearly 2% stake in Indo Tech Transformers from promoter

About this update from Bliss Gvs Pharma Limited

IIFL Asset Management has acquired nearly 2 percent equity stake in Indo Tech Transformers, the power and distribution transformers maker, from promoter via block deals on June 29.Perhaps, the stock may have reacted to the transaction, freezing at 5 percent upper circuit at Rs 3,081.9, the highest closing level since January 20, 2025, on the National Stock Exchange. In fact, it saw a consolidation breakout.IIFL Asset Management has bought 2 lakh shares (representing 1.88 percent stake) in Indo Tech for Rs 59.7 crore from promoter Shirdi Sai Electricals. Shares exchanged at a price of Rs 2,985 per share.The major buying interest was also seen in Bliss GVS Pharma which shares soared 7.71 percent to end at record closing high of Rs 529.9 amid high volumes on the National Stock Exchange, extending uptrend for second consecutive sessionInstitutional investor Mateus has bought 11.5 lakh shares (1.08 percent stake) in pharmaceutical firm Bliss GVS Pharma from Arian Investment for Rs 56.35 crore. The price at which shares exchanged was Rs 490 per share.Tube and pipe manufacturer Goodluck India also attracted healthy buying interest despite subdued market conditions, rising 5 percent to Rs 1,474.6 amid large volumes on the NSE.SageOne - Flagship Growth OE Fund has purchased additional 2.5 lakh shares (0.75 percent stake) in Garg family-owned Goodluck India for Rs 35.5 crore at Rs 1,420 per share. However, promoter Manish Garg sold 2.9 lakh shares (0.87 percent stake) in the company at Rs 1,420.81 per share, valued at Rs 41.2 crore.SageOne through its two schemes including Flagship Growth OE Fund held 2.46 percent stake in Goodluck as of March 2026.

View stock analysis, news, and events for Bliss Gvs Pharma Limited